Sanjeevan Sharma
Overview
Explore the profile of Sanjeevan Sharma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Surya Prakash V, Nair R, Soneji D, Thareja S, Rao P, Debnath J, et al.
Cureus
. 2025 Jan;
16(12):e76164.
PMID: 39840153
Background: There is no standard treatment to accelerate recovery from melphalan-induced thrombocytopenia in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT). Romiplostim, a thrombopoietin receptor agonist, has been...
2.
Gupta S, Sharma S
Indian J Hematol Blood Transfus
. 2024 Oct;
40(4):555-557.
PMID: 39469169
No abstract available.
3.
Jajula S, Naik V, Kalita B, Yanamandra U, Sharma S, Chatterjee T, et al.
J Proteomics
. 2024 Jun;
303:105224.
PMID: 38866132
Acute myeloid leukemia (AML) is an aggressive form of blood cancer and clinically highly heterogeneous characterized by the accumulation of clonally proliferative immature precursors of myeloid lineage leading to bone...
4.
Nalukettil B, Biswas A, Asthana B, Kushwaha N, Baranwal A, Sharma S
Asian J Transfus Sci
. 2024 Jan;
17(2):202-209.
PMID: 38274976
Background: Hematopoietic stem cell transplantation (HSCT) has emerged as a curative measure for life-threatening hematological disorders. It can be autologous or allogeneic depending on the disease characteristics. Providing transfusion support...
5.
Kumar R, Kapoor R, Sharma S, Pramanik S, Yanamandra U, Mishra K, et al.
Med J Armed Forces India
. 2023 Nov;
79(6):657-664.
PMID: 37981920
Background: Bone Marrow Transplant (BMT) is a curative form of therapy for many hematological disorders in both the adult and pediatric patients. The availability of BMT in the AFMS at...
6.
Chauhan V, Chatterjee K, Srivastava K, Sharma S, Saini R
Med J Armed Forces India
. 2023 Mar;
79(2):201-206.
PMID: 36969132
Background: Mothers of children diagnosed with cancer are found to have coping difficulties in various studies. Most of the studies were done on parents after their child has been newly...
7.
Yanamandra U, Yadav N, Pramanik S, Kapoor R, Mishra K, Khurana H, et al.
Indian J Hematol Blood Transfus
. 2023 Jan;
39(1):71-76.
PMID: 36699425
Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-022-01561-x.
8.
Kushwaha N, Kumar S, Sheikh M, Philip J, Sharma S, Biswas A, et al.
Med J Armed Forces India
. 2022 Jul;
78(3):296-301.
PMID: 35855709
Background: Treatment with high-dose chemotherapy and stem cell transplantation has prolonged survival in patients of multiple myeloma (MM). A dose-response relationship between number of CD34+ cells infused and leukocyte and...
9.
Chanukuppa V, More T, Taunk K, Taware R, Chatterjee T, Sharma S, et al.
RSC Adv
. 2022 May;
9(51):29522-29532.
PMID: 35531512
Multiple myeloma (MM) is the second most prevalent hematological malignancy characterized by rapid proliferation of plasma cells, which leads to overproduction of antibodies. MM affects around 15% of all hemato-oncology...
10.
Mishra K, Kumar S, Singh K, Jandial A, Sandal R, Sahu K, et al.
Ann Hematol
. 2022 Apr;
101(6):1173-1179.
PMID: 35396605
In developing countries, anti-D has been used in immune thrombocytopenia (ITP) as a cheaper alternative to human immunoglobulin. We aim to analyze the response and safety profile of anti-D in...